The PharmTech team focused on its coverage of AAPS PharmSci 360 this week, conducting interviews with experts on a range of topics including formulation platforms, AI, amorphous solid dispersions, and animal studies.
|Articles|November 2, 2013
- Pharmaceutical Technology-11-02-2013
- Volume 37
- Issue 11
Automation System Improves Operational Insight
Automation System Improves Operational Insight
The Foxboro Evo Process automation system uses a high-speed, fault-tolerant, and cyber-secure hardware platform that is an upgrade from the Foxboro I/A Series; the system integrates Triconex safety technology. The system uses a component object-based platform that allows users to perform upgrades at their own pace without halting operations. Additionally, its new applications streamline and contextualize the information plant personnel need to make business decisions. The Foxboro Evo system includes a new high-speed controller, field device manage
Articles in this issue
almost 13 years ago
Report from Brazil November 2013almost 13 years ago
Applying Catalysis to Optimize API Synthesisalmost 13 years ago
Predicting Long-Term Storage Stability of Therapeutic Proteinsalmost 13 years ago
Control of Elemental Impuritiesalmost 13 years ago
Disposable Applications in Demand by Biopharmaalmost 13 years ago
Solvent-Free Coating of Traditional and User-Friendly Dosage Formsalmost 13 years ago
Congress Revises Rules for Drug Compounding and Supply-Chain Securityalmost 13 years ago
Can Pharma Defy Gravity at the Patent Cliff?almost 13 years ago
Defining and Presenting Overkill Cycle Validationalmost 13 years ago
Preparing for Patent ExpiryRelated to this article
The agreement between CDER and OII with allow for coordinated marketing application assessments and inspections.
Shubhajit Paul, a senior research fellow in Boehringer Ingelheim’s Department of Material Analytical Sciences, spoke with PharmTech at AAPS PharmSci 360 to explain how tabletability prediction can be improved for roller-compacted formulations.
This week on PharmTech.com, experts discussed E&L suitability standards, rare disease treatment development, sourcing ingredient suppliers, the use of AI in quality control, and more.
How to test pen injector assembly interfaces from URS to FAT and SAT: verify part tracking, reject confirmation, restarts, and data transfer evidence.
Cole and Jaenisch dig into AI poisoning in pharma manufacturing, how it hides in plain sight, and who should be accountable for catching it.
Mahmood Majeed, ZS, explains why measurable AI outcomes in pharma supply chain and manufacturing jumped from 29% to 53%, and how GMP limits and GxP validation shape adoption.
FDA approves GSK's bepirovirsen for chronic hepatitis B after a 19% functional cure rate, raising oligonucleotide scale-up stakes for manufacturers.
Trending on Pharmaceutical Technology
1
AI Formulation: Regulators Want Data
2
USP 1074 Revises Excipient Safety: AAPS PharmSci 360 2026
3
FDA’s New Inspection Playbook Counts Remote Assessments and MRA Reports Toward Facility Evaluations
4
Late-Phase Impurities Need Reference Standards: AAPS PharmSci 360 2026
5